The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival and hospitalizations with lutetium (Lu)-177 vipivotide tetraxetan in veterans with underlying genomic alterations.
 
Sumrah Khan
No Relationships to Disclose
 
Vaidehi Panchal
No Relationships to Disclose
 
Daniel Eaton
No Relationships to Disclose
 
Jason Doherty
No Relationships to Disclose
 
Kara Maxwell
No Relationships to Disclose
 
Isla Garraway
No Relationships to Disclose
 
Matthew Rettig
Consulting or Advisory Role - INMune Bio
Speakers' Bureau - Bayer; Johnson & Johnson
Research Funding - Arvinas (Inst); Fortis (Inst); Novartis (Inst); Progenics
Patents, Royalties, Other Intellectual Property - I am a co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR. There are NO commercial partnerships as of yet.
Travel, Accommodations, Expenses - Johnson & Johnson
 
Ruben Raychaudhuri
No Relationships to Disclose
 
Robert Montgomery
Consulting or Advisory Role - Daiichi Sankyo/UCB Japan
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Beigene (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst)
 
Eric Knoche
Stock and Other Ownership Interests - Bristol-Myers Squibb/Pfizer (I); Cardiff Oncology; Exelixis; Gilead Sciences (I); Johnson & Johnson/Janssen (I); Karyopharm Therapeutics; Merck (I); Roche/Genentech (I)
 
Martin Schoen
Consulting or Advisory Role - ConcertAI
Research Funding - Astellas Pharma (Inst)